Intellia Therapeutics, Inc.

NasdaqGM:NTLA Stock Report

Market Cap: US$1.4b

Intellia Therapeutics, Inc. Company Information

Intellia Therapeutics, Inc.'s employee growth, exchange listings and data sources

Key Information

  • Name: Intellia Therapeutics, Inc.
  • Ticker: NTLA
  • Exchange: NasdaqGM
  • Founded: 2014
  • Industry: Biotechnology
  • Sector: Pharmaceuticals & Biotech
  • Market Cap: US$1.439b
  • Shares Outstanding: 101.85m
  • Website: https://www.intelliatx.com

Number of Employees

Location

  • Intellia Therapeutics, Inc.
  • 40 Erie Street
  • Suite 130
  • Cambridge
  • Massachusetts
  • 02139
  • United States

Listings

TickerExchangePrimary SecuritySecurity TypeCountryCurrencyListed on
NTLANasdaqGM (Nasdaq Global Market)YesCommon StockUSUSDMay 2016
38IDB (Deutsche Boerse AG)YesCommon StockDEEURMay 2016
0JBULSE (London Stock Exchange)YesCommon StockGBUSDMay 2016

Company Analysis and Financial Data Status

All financial data provided by Standard & Poor's Capital IQ.
DataLast Updated (UTC time)
Company Analysis2024/11/20 20:59
End of Day Share Price 2024/11/20 00:00
Earnings2024/09/30
Annual Earnings2023/12/31


Unless specified all financial data is based on a yearly period but updated quarterly. This is known as Trailing Twelve Month (TTM) or Last Twelve Month (LTM) Data. Learn more here.